<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30290658</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>10</Month>            <Day>23</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">1536-5964</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>97</Volume>                    <Issue>40</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                    </PubDate>                </JournalIssue>                <Title>Medicine</Title>                <ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation>            </Journal>            <ArticleTitle>Young male breast cancer, a small crowd, the survival, and prognosis?: A population-based study.</ArticleTitle>            <Pagination>                <MedlinePgn>e12686</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000012686</ELocationID>            <Abstract>                <AbstractText>Women diagnosed with breast cancer at young age often have poorprognoses. Yet, few studies have focused on the prognoses of young men with breast cancer. We therefore used Surveillance, Epidemiology, and End Results (SEER) population-based data and identified 151 male patients with breast cancer aged &lt;40 years between 1988 and 2012. Propensity score matching analysis was used to balance the clinical variables among different groups. Kaplan-Meier curves were applied to compare the survival differences. The subgroup variables on cancer-specific survival (CSS) and overall survival (OS) were analyzed by the Cox proportional hazard model. Results showed that male patients with breast cancer aged &lt;40 had a significant OS benefit compared with those aged ≥40 years (P &lt; .001). The significant difference of the CSS was not found (P &gt; .05). Compared with the male patients with breast cancer aged ≥40, those aged &lt;40 had significant OS benefit in most subgroups (P &lt; .05). Compared with the female patients with breast cancer aged &lt;40, the male patients with breast cancer aged &lt;40 had worse OS and CSS benefit only in the subgroup with progesterone receptor and estrogen receptor positive (P &lt; .05). In conclusion, we demonstrated that young male patients with breast cancer had better OS compared with elder male patients with breast cancer. However, the survival benefit was not found compared with young female patients with breast cancer.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Li</LastName>                    <ForeName>Naikun</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Central Hospital of Yidu affiliated to Weifang Medical College, Weifang.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Xiaohui</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Research Service Office, Shandong Liaocheng People's Hospital.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zhang</LastName>                    <ForeName>Hongju</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Liaocheng Infectious Disease Hospital, Liaocheng.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Wang</LastName>                    <ForeName>Haiyong</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of internal Medicine-Oncology, Shandong Cancer Hospital and Institute, Shandong Cancer Hospital affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, China.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D064888">Observational Study</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Medicine (Baltimore)</MedlineTA>            <NlmUniqueID>2985248R</NlmUniqueID>            <ISSNLinking>0025-7974</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011960">Receptors, Estrogen</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D011980">Receptors, Progesterone</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>AIM</CitationSubset>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>APMIS. 2015 Mar;123(3):223-33</RefSource>                <PMID Version="1">25556597</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2013 Feb 27;309(8):800-5</RefSource>                <PMID Version="1">23443443</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Care (Basel). 2011 Dec;6(6):446-451</RefSource>                <PMID Version="1">22419898</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2003 May-Jun;53(3):141-69</RefSource>                <PMID Version="1">12809408</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mod Pathol. 2002 Aug;15(8):853-61</RefSource>                <PMID Version="1">12181271</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2012 Sep-Oct;62(5):283-98</RefSource>                <PMID Version="1">22987332</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2010 Jan 10;28(2):232-9</RefSource>                <PMID Version="1">19996029</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Epidemiol. 2005 Nov;15(10):773-80</RefSource>                <PMID Version="1">16257362</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Oncol. 2012 Jun;29(2):554-60</RefSource>                <PMID Version="1">21573973</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2011 Jul;18(7):1837-44</RefSource>                <PMID Version="1">21484520</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2014 Oct;147(3):617-29</RefSource>                <PMID Version="1">25209005</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian J Androl. 2016 Jan-Feb;18(1):90-5</RefSource>                <PMID Version="1">25994649</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2013 Jun;24(6):1434-43</RefSource>                <PMID Version="1">23425944</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Surg Oncol. 2009 Sep 1;100(3):248-51</RefSource>                <PMID Version="1">19330813</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Cancer Inst. 2013 Jul 3;105(13):978-88</RefSource>                <PMID Version="1">23723422</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2007 Apr 15;109(8):1471-7</RefSource>                <PMID Version="1">17342768</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2017 Sep 11;17(1):641</RefSource>                <PMID Version="1">28893223</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2012 Feb;131(3):1061-6</RefSource>                <PMID Version="1">22080245</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer (Dove Med Press). 2015 Dec 21;8:1-12</RefSource>                <PMID Version="1">26730210</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Yonsei Med J. 2008 Dec 31;49(6):978-86</RefSource>                <PMID Version="1">19108022</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Chir (Paris). 1995 Mar;132(3):131-6</RefSource>                <PMID Version="1">7782385</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Medicine (Baltimore). 2017 Jan;96(4):e5998</RefSource>                <PMID Version="1">28121956</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Clin Oncol. 2014 Apr;19(2):280-7</RefSource>                <PMID Version="1">23640121</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2015 Aug 27;10(8):e0136670</RefSource>                <PMID Version="1">26313461</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pan Afr Med J. 2009 Nov 16;3:15</RefSource>                <PMID Version="1">21532724</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Breast Cancer. 2014;2014:685842</RefSource>                <PMID Version="1">25349739</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2009 May;115(2):429-30</RefSource>                <PMID Version="1">18478326</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2018 Apr;38:132-135</RefSource>                <PMID Version="1">29316513</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2011 Aug 04;11:335</RefSource>                <PMID Version="1">21816051</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Res Notes. 2011 Jun 29;4:219</RefSource>                <PMID Version="1">21714875</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pathol Res Pract. 2012 Mar 15;208(3):163-6</RefSource>                <PMID Version="1">22361037</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):747-52</RefSource>                <PMID Version="1">24138917</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2018 Feb 13;18(1):179</RefSource>                <PMID Version="1">29433453</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer. 2004 Jul 1;101(1):51-7</RefSource>                <PMID Version="1">15221988</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2013 Jun;139(2):561-9</RefSource>                <PMID Version="1">23690143</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018567" MajorTopicYN="N">Breast Neoplasms, Male</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>                <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D044469" MajorTopicYN="N">Continental Population Groups</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D060787" MajorTopicYN="N">Neoplasm Grading</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011960" MajorTopicYN="N">Receptors, Estrogen</DescriptorName>                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011980" MajorTopicYN="N">Receptors, Progesterone</DescriptorName>                <QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D018426" MajorTopicYN="N">SEER Program</DescriptorName>            </MeshHeading>        </MeshHeadingList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>24</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30290658</ArticleId>            <ArticleId IdType="doi">10.1097/MD.0000000000012686</ArticleId>            <ArticleId IdType="pii">00005792-201810050-00072</ArticleId>            <ArticleId IdType="pmc">PMC6200462</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>